Perrigo to Attend Barclays 18th Annual Global Consumer Staples Conference

Rhea-AI Summary

Perrigo (NYSE:PRGO), a leading self-care company, announced that its President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra will participate in one-on-one investor meetings at the Barclays Global Consumer Staples Conference on September 3rd, 2025.

The company, with over a century of experience, specializes in over-the-counter (OTC) self-care products in North America and Europe. Their business model combines store brand private label offerings with branded products including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.

DUBLIN, Aug. 20, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to participate in one-on-one investor meetings at the Barclays Global Consumer Staples Conference on Wednesday, September 3^rd, 2025.

About Perrigo  

Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.

Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill^®, Mederma^®, Compeed^®, EllaOne^®, and Jungle Formula^®.

For more information, visit www.perrigo.com.

Forward-Looking Statements 

This press release includes, and the matters discussed at the Barclays 18th Annual Global Consumer Staples Conference will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024.

Perrigo Contact

Bradley Joseph, Vice President, Global Investor Relations & Corporate Communications, (269) 686-3373, E-mail: bradley.joseph@perrigo.com

Nicholas Gallagher, Senior Manager, Global Investor Relations & Corporate Communications, (269) 686-3238, E-mail: nicholas.gallagher@perrigo.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/perrigo-to-attend-barclays-18th-annual-global-consumer-staples-conference-302534524.html

SOURCE Perrigo Company plc

FAQ

When is Perrigo (PRGO) presenting at the Barclays Global Consumer Staples Conference 2025?

Perrigo's management will participate in one-on-one investor meetings on September 3rd, 2025 at the Barclays Global Consumer Staples Conference.

Who will represent Perrigo (PRGO) at the Barclays Conference 2025?

President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra will represent Perrigo at the conference.

What are Perrigo's (PRGO) main branded products?

Perrigo's leading brands include Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.

What is Perrigo's (PRGO) business model?

Perrigo operates a unique business model where cash-generating store brand private label offerings fund investments in their leading branded products.